CB
WST icon

Cooke & Bieler’s West Pharmaceutical WST Stock Holding History

Cooke & Bieler’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-406,002
Closed -$14.3M – 102
2013
Q2 		$14.3M Buy
+406,002
New +$13.4M 0.34% 66

Other funds holding WST

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Cooke & Bieler's WST Position: Q3 2013 in Review

Cooke & Bieler sold out of West Pharmaceutical (WST) in Q3 2013, closing a stake of 406,002 shares — an estimated $14.3M sold.

Cooke & Bieler first reported a position in WST in Q2 2013 and held it in 1 quarter. The position peaked at $14.3M in Q2 2013. 205 funds tracked by Wall St. Rank hold WST as of Q3 2013.

  • Cooke & Bieler reported no remaining West Pharmaceutical position as of Q3 2013 after selling out during the quarter.
  • Cooke & Bieler sold 406,002 West Pharmaceutical shares in Q3 2013, an estimated $14.3M.
  • Cooke & Bieler first reported a position in West Pharmaceutical in Q2 2013 and held it in 1 quarter.
  • Cooke & Bieler's West Pharmaceutical position peaked at $14.3M in Q2 2013.
  • 205 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2013.

Based on Cooke & Bieler's 13F filing for Q3 2013, filed 14 Nov 2013.